-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE: 82.2% OF ALL ABBV-295 TREATED PARTICIPANTS REPORTED MILD ADVERSE EVENTS AS HIGHEST REPORTED AE SEVERITY

Reuters·09/30/2026 09:45:00

Please log in to view news